AAAAAA

   
Results: 1-19 |
Results: 19
P53 PROTEIN ACCUMULATION PREDICTS POOR RESPONSE TO TAMOXIFEN THERAPY OF PATIENTS WITH RECURRENT BREAST-CANCER
Authors: BERNS EMJJ KLIJN JGM VANPUTTEN WLJ DEWITTE HH LOOK MP GELDER MEM WILLMAN K PORTENGEN H BENRAAD TJ FOEKENS JA
Citation: Emjj. Berns et al., P53 PROTEIN ACCUMULATION PREDICTS POOR RESPONSE TO TAMOXIFEN THERAPY OF PATIENTS WITH RECURRENT BREAST-CANCER, Journal of clinical oncology, 16(1), 1998, pp. 121-127
PREDICTIVE VALUE OF SRC-1 FOR TAMOXIFEN RESPONSE OF RECURRENT BREAST-CANCER
Authors: BERNS EMJJ VANSTAVEREN IL KLIJN JGM FOEKENS JA
Citation: Emjj. Berns et al., PREDICTIVE VALUE OF SRC-1 FOR TAMOXIFEN RESPONSE OF RECURRENT BREAST-CANCER, Breast cancer research and treatment, 48(1), 1998, pp. 87-92
HIGH PREVALENCE OF CODON 213(ARG-]STOP) MUTATIONS OF THE TP53 GENE INHUMAN OVARIAN-CANCER IN THE SOUTHWESTERN PART OF THE NETHERLANDS
Authors: SCHUYER M HENZENLOGMANS SC VANDERBURG MEL FIERET EJH KLIJN JGM FOEKENS JA BERNS EMJJ
Citation: M. Schuyer et al., HIGH PREVALENCE OF CODON 213(ARG-]STOP) MUTATIONS OF THE TP53 GENE INHUMAN OVARIAN-CANCER IN THE SOUTHWESTERN PART OF THE NETHERLANDS, International journal of cancer, 76(3), 1998, pp. 299-303
MUTATIONS IN RESIDUES OF TP53 THAT DIRECTLY CONTACT DNA PREDICT POOR OUTCOME IN HUMAN PRIMARY BREAST-CANCER
Authors: BERNS EMJJ VANSTAVEREN IL LOOK MP SMID M KLIJN JGM FOEKENS JA
Citation: Emjj. Berns et al., MUTATIONS IN RESIDUES OF TP53 THAT DIRECTLY CONTACT DNA PREDICT POOR OUTCOME IN HUMAN PRIMARY BREAST-CANCER, British Journal of Cancer, 77(7), 1998, pp. 1130-1136
RELATIONSHIP OF P53, UPA, PS2, EGF-R, AND C-ERBB2, WITH RESPONSE TO SYSTEMIC TREATMENT IN RECURRENT BREAST-CANCER PATIENTS
Authors: KLIJN JGM BERNS EMJJ LOOK MP MEIJERVANGELDER ME FOEKENS JA
Citation: Jgm. Klijn et al., RELATIONSHIP OF P53, UPA, PS2, EGF-R, AND C-ERBB2, WITH RESPONSE TO SYSTEMIC TREATMENT IN RECURRENT BREAST-CANCER PATIENTS, European journal of cancer, 33, 1997, pp. 883-883
PROGNOSTIC VALUE OF TP53 PROTEIN ACCUMULATION IN HUMAN PRIMARY BREAST-CANCER - AN ANALYSIS BY LUMINOMETRIC IMMUNOASSAY ON 1491 TUMOR CYTOSOLS
Authors: BERNS EMJJ DEWITTE HH KLIJN JGM WILLMAN K LOOK MP MEIJERVANGELDER ME BENRAAD TJ FOEKENS JA
Citation: Emjj. Berns et al., PROGNOSTIC VALUE OF TP53 PROTEIN ACCUMULATION IN HUMAN PRIMARY BREAST-CANCER - AN ANALYSIS BY LUMINOMETRIC IMMUNOASSAY ON 1491 TUMOR CYTOSOLS, Anticancer research, 17(4B), 1997, pp. 3003-3006
TP53 AND MYC GENE ALTERATIONS INDEPENDENTLY PREDICT POOR-PROGNOSIS INBREAST-CANCER PATIENTS
Authors: BERNS EMJJ KLIJN JGM SMID M VANSTAVEREN IL LOOK MP VANPUTTEN WLJ FOEKENS JA
Citation: Emjj. Berns et al., TP53 AND MYC GENE ALTERATIONS INDEPENDENTLY PREDICT POOR-PROGNOSIS INBREAST-CANCER PATIENTS, Genes, chromosomes & cancer, 16(3), 1996, pp. 170-179
EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND ITS INHIBITOR PAI-1 IN BENIGN, BORDERLINE, MALIGNANT PRIMARY AND METASTATIC OVARIAN-TUMORS
Authors: VANDERBURG MEL HENZENLOGMANS SC BERNS EMJJ VANPUTTEN WLJ KLIJN JGM FOEKENS JA
Citation: Mel. Vanderburg et al., EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND ITS INHIBITOR PAI-1 IN BENIGN, BORDERLINE, MALIGNANT PRIMARY AND METASTATIC OVARIAN-TUMORS, International journal of cancer, 69(6), 1996, pp. 475-479
PROGNOSTIC-SIGNIFICANCE OF TP53 ACCUMULATION IN HUMAN PRIMARY BREAST-CANCER - COMPARISON BETWEEN A RAPID QUANTITATIVE IMMUNOASSAY AND SSCP ANALYSIS
Authors: DEWITTE HH FOEKENS JA LENNERSTRAND J SMID M LOOK MP KLIJN JGM BENRAAD TJ BERNS EMJJ
Citation: Hh. Dewitte et al., PROGNOSTIC-SIGNIFICANCE OF TP53 ACCUMULATION IN HUMAN PRIMARY BREAST-CANCER - COMPARISON BETWEEN A RAPID QUANTITATIVE IMMUNOASSAY AND SSCP ANALYSIS, International journal of cancer, 69(2), 1996, pp. 125-130
SPORADIC CDKN2 (MTS1 P16(INK4)) GENE ALTERATIONS IN HUMAN OVARIAN-TUMORS/
Authors: SCHUYER M VANSTAVEREN IL KLIJN JGM VANDERBURG MEL STOTER G HENZENLOGMANS SC FOEKENS JA BERNS EMJJ
Citation: M. Schuyer et al., SPORADIC CDKN2 (MTS1 P16(INK4)) GENE ALTERATIONS IN HUMAN OVARIAN-TUMORS/, British Journal of Cancer, 74(7), 1996, pp. 1069-1073
ONCOGENE AMPLIFICATION AND PROGNOSIS IN BREAST-CANCER - RELATIONSHIP WITH SYSTEMIC TREATMENT
Authors: BERNS EMJJ FOEKENS JA VANSTAVEREN IL VANPUTTEN WLJ DEKONING HYWCM PORTENGEN H KLIJN JGM
Citation: Emjj. Berns et al., ONCOGENE AMPLIFICATION AND PROGNOSIS IN BREAST-CANCER - RELATIONSHIP WITH SYSTEMIC TREATMENT, Gene, 159(1), 1995, pp. 11-18
ASSOCIATION BETWEEN RB-1 GENE ALTERATIONS AND FACTORS OF FAVORABLE PROGNOSIS IN HUMAN BREAST-CANCER, WITHOUT EFFECT ON SURVIVAL
Authors: BERNS EMJJ DEKLEIN A VANPUTTEN WLJ VANSTAVEREN IL BOOTSMA A KLIJN JGM FOEKENS JA
Citation: Emjj. Berns et al., ASSOCIATION BETWEEN RB-1 GENE ALTERATIONS AND FACTORS OF FAVORABLE PROGNOSIS IN HUMAN BREAST-CANCER, WITHOUT EFFECT ON SURVIVAL, International journal of cancer, 64(2), 1995, pp. 140-145
MOLECULAR-GENETIC EVIDENCE FOR UNIFOCAL ORIGIN OF ADVANCED EPITHELIALOVARIAN-CANCER AND FOR MINOR CLONAL DIVERGENCE
Authors: ABELN ECA KUIPERSDIJKSHOORN NJ BERNS EMJJ HENZENLOGMANS SC FLEUREN GJ CORNELISSE CJ
Citation: Eca. Abeln et al., MOLECULAR-GENETIC EVIDENCE FOR UNIFOCAL ORIGIN OF ADVANCED EPITHELIALOVARIAN-CANCER AND FOR MINOR CLONAL DIVERGENCE, British Journal of Cancer, 72(5), 1995, pp. 1330-1336
INFREQUENT CDKN2 (MTS1 P16) GENE ALTERATIONS IN HUMAN PRIMARY BREAST-CANCER/
Authors: BERNS EMJJ KLIJN JGM SMID M VANSTAVEREN IL GRUIS NA FOEKENS JA
Citation: Emjj. Berns et al., INFREQUENT CDKN2 (MTS1 P16) GENE ALTERATIONS IN HUMAN PRIMARY BREAST-CANCER/, British Journal of Cancer, 72(4), 1995, pp. 964-967
IDENTIFICATION OF PROGNOSTIC FACTORS
Authors: FOEKENS JA BERNS EMJJ LOOK MP VANPUTTEN WLJ KLIJN JGM
Citation: Ja. Foekens et al., IDENTIFICATION OF PROGNOSTIC FACTORS, Pathologie et biologie, 42(10), 1994, pp. 954-955
KI-67 STAINING IN BENIGN, BORDERLINE, MALIGNANT PRIMARY AND METASTATIC OVARIAN-TUMORS - CORRELATION WITH STEROID-RECEPTORS, EPIDERMAL-GROWTH-FACTOR RECEPTOR AND CATHEPSIN-D
Authors: HENZENLOGMANS SC FIERET EJH BERNS EMJJ VANDERBURG MEL KLIJN JGM FOEKENS JA
Citation: Sc. Henzenlogmans et al., KI-67 STAINING IN BENIGN, BORDERLINE, MALIGNANT PRIMARY AND METASTATIC OVARIAN-TUMORS - CORRELATION WITH STEROID-RECEPTORS, EPIDERMAL-GROWTH-FACTOR RECEPTOR AND CATHEPSIN-D, International journal of cancer, 57(4), 1994, pp. 468-472
THE PROGNOSTIC VALUE OF EPIDERMAL GROWTH-FACTOR RECEPTORS, DETERMINEDBY BOTH IMMUNOHISTOCHEMISTRY AND LIGAND-BINDING ASSAYS, IN PRIMARY EPITHELIAL OVARIAN-CANCER - A PILOT-STUDY
Authors: VANDERBURG MEL HENZENLOGMANS SC FOEKENS JA BERNS EMJJ RODENBURG CJ VANPUTTEN WLJ KLIJN JGM
Citation: Mel. Vanderburg et al., THE PROGNOSTIC VALUE OF EPIDERMAL GROWTH-FACTOR RECEPTORS, DETERMINEDBY BOTH IMMUNOHISTOCHEMISTRY AND LIGAND-BINDING ASSAYS, IN PRIMARY EPITHELIAL OVARIAN-CANCER - A PILOT-STUDY, European journal of cancer, 29A(14), 1993, pp. 1951-1957
CELL BIOLOGICAL FACTORS ASSOCIATED WITH THE RESPONSE OF BREAST-CANCERTO SYSTEMIC TREATMENT
Authors: KLIJN JGM BERNS EMJJ BONTENBAL M FOEKENS J
Citation: Jgm. Klijn et al., CELL BIOLOGICAL FACTORS ASSOCIATED WITH THE RESPONSE OF BREAST-CANCERTO SYSTEMIC TREATMENT, Cancer treatment reviews, 19, 1993, pp. 45-63
PROGNOSTIC FACTORS AND RESPONSE TO THERAPY IN BREAST-CANCER
Authors: KLIJN JGM BERNS EMJJ FOEKENS JA
Citation: Jgm. Klijn et al., PROGNOSTIC FACTORS AND RESPONSE TO THERAPY IN BREAST-CANCER, Cancer surveys, 18, 1993, pp. 165-198
Risultati: 1-19 |